In today’s rapidly evolving technological landscape, generative artificial intelligence (AI) has emerged as a powerful tool for various industries, and it seems like enterprises are fast to adopt it. Generative AI refers to the use of machine learning algorithms to generate original and creative content such as images, text, or music.
By Noam Harel In the ever-changing landscape of the pharmaceutical industry, the integration of generative artificial intelligence (AI) holds immense promise and potential alongside risk, patient and consumer safety and tight regulation. Generative AI refers to the ability of machines to autonomously create new and unique content, ideas, or solutions.
By Noam Harel In the fast-paced and ever-evolving business landscape, innovation has become the lifeblood of success. Yet, many organizations fail to harness the full potential of innovation due to a significant gap between their business units. This gap, like a hidden chasm, prevents the sharing of best practices, stifling growth and hindering progress.
Generative AI stands out from other technological breakthroughs due to its remarkable velocity and unprecedented speed. In a matter of mere months since its initial emergence in the limelight, this cutting-edge innovation has already achieved scalability, aiming to attain substantial return on investment. However, it is imperative to effectively harness this formidable technology, ensuring that it can deploy on a large scale and yield outcomes that garner trust from your business stakeholders.
It seems like we are witnessing a new quantum leap of technological advancement, with Generative AI taking the world by storm earlier this year. Generative AI (GenAI) has emerged as a powerful tool that combines artificial intelligence with creativity, empowering machines to generate original content, such as images, music, and even text, that imitates human-like creativity from structured and unstructured data.
When approaching machine learning operations, the options can be overwhelming. There may be multiple solutions available for each step in the process, and the most popular (usually open source tools) may not necessarily be good or easy to use, but they are free.
The first secure, enterprise-grade generative AI platform We have an exciting announcement! On Thursday, May 18, we released ClearGPT, the first generative AI platform that transcends enterprise ChatGPT challenges. ClearGPT is the only secure, enterprise-grade platform offering state-of-the-art LLMs, tailored to your business data and running securely on your network, to power enterprise AI transformation. Prefer to watch the 2-minute video and see how it works? Watch now.
Making a Question Answering (QA) bot that can cite your own documentation and help channels is now possible thanks to chatGPT and Langchain, an open-source tool that cleverly uses chatGPT but doesn’t require retraining it. But it’s a far cry from “out of the box.” One example is that you have to get the prompt just right. To get an LLM (large language model) to do exactly what you want, your instructions will have to be very clear, so what if we automate that too?
by Victor Sonck, Developer Advocate, ClearML Sarcasm can be difficult to detect in text, especially for machines. However, with the power of large language models, it’s possible to create a tool that can identify sarcastic comments with high accuracy. That’s exactly what the ClearML team did with their latest project: a sarcasm detector that combines various ClearML tools to showcase the capabilities of MLOps.
The world of artificial intelligence and machine learning is constantly evolving, with new challenges and innovations emerging every day. Tzag Elita is a leading provider of HPC and AI solutions in Israel, and understands the importance of staying ahead of the curve and delivering cutting-edge solutions to their customers. That’s why ClearML is excited to announce our partnership with Tzag Elita.
